| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_deaa4d6b51825480b6d8314b6b0e3679
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7bce595c861dba361078ba893e4713be |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-0093 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555 |
| filingDate |
2006-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13e3e1e49d5202b9cd76d69781a8cab2 |
| publicationDate |
2007-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007021852-A2 |
| titleOfInvention |
Transplatinum complexes with n2o2 donor sets as cytotoxic and antitumor agents |
| abstract |
Trans-platinum compounds comprising carboxylato groups are disclosed, with anti- cancer usefulness. The carboxylato groups participate in solubilizing trans-platinum compounds to which they are attached. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8729286-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010027428-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9133225-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9034862-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9593139-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9265747-B2 |
| priorityDate |
2005-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |